Top entities: Coya Therapeutics, ClinActiv Holdings, Toronto Stock Exchange, Canada — Superior Court of Justice (Ontario), Canada.

What category does this event fall under?

Business — classified as acquisition.

What is the market impact?

Direct. The acquisition of Coya Therapeutics Inc.

What is the sentiment of coverage?

Aggregate sentiment score: 70 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Is this event still developing?

This is an active story, last updated Jun 02, 2026. Coverage continues to evolve.

Business acquisition

ClinActiv acquires Crescita Therapeutics

Q: When did this event occur?

First reported May 20, 2026; last updated Jun 02, 2026.

Q: What were the key actions taken?

ClinActiv Holdings acquire Coya Therapeutics · Canada — Superior Court of Justice (Ontario) approved plan · Coya Therapeutics delist shares Toronto Stock Exchange

Analysis based on 10 articles · First reported May 20, 2026 · Last updated Jun 02, 2026

Sentiment

Attention

Articles

Market Impact

Direct

Live prominence charts, article sentiment distribution, and event development timeline available on the NewsDesk Dashboard

Market Impact

The acquisition of Coya Therapeutics Inc. by ClinActiv Holdings Inc. will result in Coya Therapeutics Inc. shares being delisted from the Toronto Stock Exchange, directly impacting its shareholders who will receive $0.80 per share. This event signifies a consolidation in the dermatology and consumer health sector, potentially affecting market dynamics for similar companies.

Pharmaceuticals Biotechnology

Event Summary

Coya Therapeutics Inc., a Canadian commercial dermatology company, is being acquired by ClinActiv Holdings Inc., a global dermatology and consumer health platform. The acquisition is structured as a plan of arrangement, with ClinActiv's wholly-owned subsidiary purchasing all outstanding common shares of Coya Therapeutics Inc. for $0.80 per share in cash. The Canada — Superior Court of Justice (Ontario) (Commercial List) has approved the arrangement, which is expected to be completed on June 3, 2026. Following the completion, Coya Therapeutics Inc. shares will be delisted from the Toronto Stock Exchange, and the company will cease to be a reporting issuer under Canadian securities laws. This move allows ClinActiv Holdings Inc. to expand its portfolio and market presence.

Key Actions

100 ClinActiv Holdings acquire Coya Therapeutics

80 Canada — Superior Court of Justice (Ontario) approved plan

70 Coya Therapeutics delist shares Toronto Stock Exchange

Entities Involved

stock

Coya Therapeutics

Coya Therapeutics Inc. is being acquired by ClinActiv Holdings Inc. for $0.80 per share, leading to its delisting from the Toronto Stock Exchange and ceasing to be a reporting issuer.

Importance 100 Sentiment 70

priv

ClinActiv Holdings

ClinActiv Holdings Inc. is acquiring Coya Therapeutics Inc., expanding its global dermatology and consumer health platform through this strategic acquisition.

Importance 90 Sentiment 70

exch

Toronto Stock Exchange

The Toronto Stock Exchange will delist Coya Therapeutics Inc. shares upon the completion of the acquisition.

Importance 20 Sentiment 0

govactor

Canada — Superior Court of Justice (Ontario)

The Canada — Superior Court of Justice (Ontario) (Commercial List) approved the plan of arrangement for the acquisition.

Importance 10 Sentiment 0

cnt

Canada

Coya Therapeutics Inc. is a Canadian company, and the acquisition involves Canadian securities regulators.

Importance 10 Sentiment 0

NEWSDESK

Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard